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beneﬁciaries
Andres Schanzer, MD,a Louis M. Messina, MD,a Kaushik Ghosh, PhD,b Jessica P. Simons, MD, MPH,a
William P. Robinson III, MD,a Francesco A. Aiello, MD,a Robert J. Goldberg, PhD,a and
Allison B. Rosen, MD, MPH, ScD,a,b Worcester and Cambridge, Mass
Objective: Lifelong imaging follow-up is essential to the safe and appropriate management of patients who undergo
endovascular abdominal aortic aneurysm repair (EVAR). We sought to evaluate the rate of compliance with imaging
follow-up after EVAR and to identify factors associated with being lost to imaging follow-up.
Methods:We identiﬁed a 20% sample of continuously enrolled Medicare beneﬁciaries who underwent EVAR between 2001
and 2008. Using data through 2010 from Medicare Inpatient, Outpatient, and Carrier ﬁles, we identiﬁed all abdominal
imaging studies that may have been performed for EVAR follow-up. Patients were considered lost to annual imaging
follow-up if they did not undergo any abdominal imaging study within their last 2 years of follow-up. Multivariable
models were constructed to identify independent factors associated with being lost to annual imaging follow-up.
Results: Among 19,962 patients who underwent EVAR, the incidence of loss to annual imaging follow-up at 5 years
after EVAR was 50%. Primary factors associated with being lost to annual imaging follow-up were advanced age
(age 65-69 years, reference; age 75-79 years: hazard ratio [HR], 1.23; 95% conﬁdence interval [CI], 1.15-1.32;
age 80-85 years: HR, 1.45; 95% CI, 1.35-1.55; age >85 years: HR, 2.03; 95% CI, 1.88-2.20) and presentation with an urgent/
emergent intact aneurysm (HR, 1.27; 95% CI, 1.20-1.35) or ruptured aneurysm (HR, 1.84; 95% CI, 1.63-2.08). Additional
independent factors included several previously diagnosed chronic diseases and South and West regions of the United States.
Conclusions: Annual imaging follow-up compliance after EVAR in the United States is signiﬁcantly below recommended
levels. Quality improvement efforts to encourage improved compliance with imaging follow-up, especially in older
patients with multiple comorbidities and in those who underwent EVAR urgently or for rupture, are necessary. (J Vasc
Surg 2015;61:16-22.)The management of abdominal aortic aneurysms
(AAAs) has traditionally depended on open surgical
repair.1,2 Recent advances in catheter-based, endovascular
techniques have led to a substantial increase in the propor-
tion of AAAs managed with endovascular aortic aneurysm
repair (EVAR). In 2006, 21,725 EVAR procedures were
performed in the United States, exceeding for the ﬁrst
time the number of open surgical AAA repairs.3 Currently,the University of Massachusetts Medical School, Worcestera; and the
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performed by EVAR.4
Multiple guidelines recommend annual lifelong imaging
follow-up after EVAR to identify and to correct complications
such as endoleaks or residual aortic sac enlargement and
thereby prevent death due to aneurysm rupture after
EVAR.5,6 Recent evidence from several longitudinal investiga-
tions indicates that rates of late aneurysm sac enlargement are
unexpectedly high, increasing the risk of death due to rupture
after EVAR.7-9 In a study of 27 patients presenting with AAA
rupture after EVAR during the period 2002-2009, approxi-
mately three quarters had been lost to follow-up before
rupture.10 Accordingly, annual lifelong imaging follow-up
with computed tomography (CT), magnetic resonance imag-
ing (MRI), or duplex ultrasound is essential to the safe and
appropriate management of patients undergoing EVAR.
Despite the critical importance of annual lifelong
imaging follow-up after EVAR, little is known about
compliance with this requirement.11,12 We hypothesized
that among Medicare beneﬁciaries treated with EVAR, a
signiﬁcant proportion of patients are lost to annual imag-
ing follow-up and that there are several patient character-
istics associated with loss to annual imaging follow-up. To
test this hypothesis, we examined Medicare claims data to
identify a group of patients who underwent EVAR be-
tween 2001 and 2008 and estimated the proportion lost
Table I. Baseline characteristics of Medicare beneﬁciaries
who underwent endovascular aneurysm repair (EVAR)
between 2001 and 2008 (N ¼ 19,962)
Variable No. (%)
Men 16,368 (82)
Age, years
65-69 3393 (17)
70-74 4791 (24)
75-79 5390 (27)
80-84 4192 (21)
$85 2196 (11)
Race
White 18,764 (94)
Black 599 (3)
Other 599 (3)
Mean family income quartile
Lowest quartile (0%-25%) 4969 (24.89)
Low medium quartile (26%-50%) 4988 (24.99)
High medium quartile (51%-75%) 4954 (24.82)
Highest quartile (76%-100%) 5051 (25.30)
Region of the United States
Northeast 3793 (19)
Midwest 5390 (27)
South 8384 (42)
West 2395 (12)
Comorbidities
Ischemic heart disease 9182 (46)
Congestive heart failure 2595 (13)
Cerebrovascular disease 2195 (11)
Chronic obstructive pulmonary disease 6387 (32)
Chronic renal dysfunction 1596 (8)
Diabetes 3992 (20)
Cancer 2994 (15)
Hypertension 14,173 (71)
Hyperlipidemia 10,779 (54)
Presentation
Elective intact aneurysm 16,856 (84)
Urgent or emergent intact aneurysm 2626 (13)
Ruptured aneurysm 480 (2)
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up. A secondary objective of this observational study was
to examine patient-related factors associated with loss to
annual imaging follow-up for which increased efforts
directed at follow-up compliance are warranted.
METHODS
Data sources. We conducted a retrospective cohort
study using 2001-2010 enrollment and claims data for a
20% national sample of Medicare beneﬁciaries selected by
the Centers forMedicare andMedicaid Services in construct-
ing their standard Part B (physician services) claims ﬁles
(needed to identify imaging follow-up in our study). Data
on EVAR procedures were obtained from the U.S. Medicare
Provider Analysis and Review ﬁles, which contain hospital
discharge abstracts for the acute care hospitalizations of all
Medicare beneﬁciaries with Part A coverage. The data include
admission and discharge dates, International Classiﬁcation of
Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-
CM) diagnosis and procedure codes and dates, admission
type (categorized as elective, urgent, and emergent), and
discharge disposition. Imaging data were obtained from
Hospital Inpatient, Outpatient, and Carrier ﬁles. These ﬁles
were linked to Medicare Denominator ﬁles, which include
information on beneﬁciaries’ date of birth, sex, race/ethnicity
(categorized as black, white, or other), enrollment status,
region of residence (Midwest, Northeast, South, or West),
and vital status (including date of death). Follow-up imaging
was evaluated for all patients through December 31, 2010.
Cohort identiﬁcation. The study cohort was deﬁned
by identifying Medicare fee-for-service beneﬁciaries
65 years or older who underwent EVAR between January
1, 2001, and December 31, 2008. Eligibility was limited to
those continuously enrolled in Medicare Parts A and B (as
identiﬁed through Denominator ﬁles) from the time of
their EVAR until the end of the study period or death.
Patients were excluded if they resided outside the United
States or were enrolled in a Medicare health maintenance
organization during the study window.
Patients who underwent EVAR were identiﬁed on
the basis of an ICD-9 diagnosis code for AAA with (441.3)
or without rupture (441.4) as well as an ICD-9 procedure
code for EVAR (39.71). To limit the cohort to patients
who underwent EVAR for infrarenal AAA and to minimize
misclassiﬁcation errors, patients were excluded for diagnosis
and procedure codes related to the thoracic aorta or visceral
segment aorta (Supplementary Table I, online only).
Identiﬁcation of imaging studies performed during
EVAR follow-up. To identify any abdominal imaging
study that might have been performed for EVAR follow-
up, the Inpatient, Outpatient, and Carrier ﬁles were
queried for billing codes consistent with an abdominal
or pelvic CT, MRI, or duplex ultrasound study
(Supplementary Table II, online only). The billing codes
included were intentionally broad to mitigate the risk of
missing potentially relevant imaging studies.
Patient covariates. Patient sociodemographic charac-
teristics examined included age, sex, race, and residentiallocation by region of the United States. Median household
income by the beneﬁciary’s zip code of residence was ob-
tained from U.S. Census ﬁles.13 The indication for EVAR
was classiﬁed as elective intact aneurysm, urgent or emer-
gent intact aneurysm, or ruptured aneurysm. A partial list
of relevant comorbidities used in the Klabunde adaptation
of the Charlson Comorbidity Index was identiﬁed by a 1-
year look-back from the index EVAR admission date.14,15
Comorbidities included ischemic heart disease, congestive
heart failure, cerebrovascular disease, chronic obstructive
pulmonary disease, chronic renal dysfunction, diabetes,
cancer, hypertension, and hyperlipidemia.
Outcome measures. The primary study end point was
loss to annual imaging follow-up. Patients were considered
lost to annual imaging follow-up in the following two situations:
1. If the patient was alive at the end of the follow-up
period (December 31, 2010) and did not have any
claim submitted for an imaging study (CT, MRI,
or duplex ultrasound) within the 2 years before the
end of the follow-up period.
Fig 1. The number of hospitalizations for endovascular aneurysm repair (EVAR) procedures per 100,000 Medicare
beneﬁciaries between 2001 and 2008.
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did not have any claim submitted for an imaging
study (CT, MRI, or duplex ultrasound) within the
2 years before the date of death.
A 2-year span was used to provide an adequate time
window to ensure that loss to annual imaging follow-up
was not overestimated.
The secondary end point evaluated was the presence of
a prolonged imaging gap after EVAR. Patients were
considered to have a prolonged imaging gap if they did
not undergo at least one imaging study during each 2-
year interval that they were alive after EVAR.
Statistical methods. Annual incidence of EVAR proce-
dures performed between 2001 and 2008 is reported as pro-
cedure rates per 100,000 Medicare beneﬁciaries. After a
patient was determined to be lost to annual imaging follow-
up by the methodology presented before, the time-to-event
occurrence of loss to annual imaging follow-up was analyzed
by theKaplan-Meiermethod,with the timeduration assigned
being 2 years from the last obtained imaging study. Between-
group differences in stratiﬁed analyses were compared by the
log-rank test. For all survival analyses, observations were
censored at the time of death, and Kaplan-Meier curves were
generated without the use of a smoothing function. To
identify independent predictors of loss to annual imaging
follow-up, all potential sociodemographic risk factors in
Table Iwere introduced into amultivariableCoxproportional
hazards model using backward stepwise selection.
The proportion of patients with a prolonged imaging
gap for each 2-year window after EVAR (0-1.9 years, 2-
3.9 years, 4-5.9 years, and 6-8 years) was calculated at
the patient level by the following equation:
100%

No: of patients with$1 imaging study during 2-year interval
No: of patients alive during 2-year interval
 100

All analyses were performed with SAS 9.2 (SAS Insti-
tute, Cary, NC); two-tailed P values < .05 were considered
statistically signiﬁcant. This study was approved by the
Institutional Review Board at the University ofMassachusetts Medical School and patient consent was
waived for this study.
RESULTS
The study population consisted of 19,962 Medicare
beneﬁciaries aged 65 years and older who underwent
EVAR between 2001 and 2008. The patients were primar-
ily men (82%) and white (94%), with an average age of
76.3 years and a median household income of $49,746,
representing all regions of the United States (Table I).
Patients who underwent EVAR had a high burden of car-
diovascular risk factors including ischemic heart disease
(46%), diabetes (20%), hypertension (71%), and hyperlipid-
emia (54%). Eighty-four percent of EVARs were per-
formed electively, 13% urgently or emergently for intact
aneurysm, and 2% emergently for ruptured aneurysm.
During the study period, the absolute number of hos-
pitalizations for EVAR increased markedly (from 1400 in
2001 to 3529 in 2008), representing a more than 2.5-
fold increase in the annual incidence of EVAR procedures
(from 25 EVARs per 100,000 Medicare beneﬁciaries in
2001 to 65 EVARs per 100,000 Medicare beneﬁciaries
in 2008; P value for trend < .001) (Fig 1).
Loss to annual imaging follow-up. The mean dura-
tion of follow-up was 5 6 2.6 years. The proportion of
patients lost to annual imaging follow-up on Kaplan-Meier
analysis at 1, 3, and 5 years after EVAR was 22% (standard
error, .0003), 38% (standard error, .004), and 50% (stan-
dard error, .004), respectively. Loss to annual imaging
follow-up appeared to increase steadily throughout the
study period, with no evidence of a plateau or slow-down
in the slope of the Kaplan-Meier curve (Fig 2).
On univariable analysis, the proportion of patients lost
to annual imaging follow-up was signiﬁcantly associated
with the relative urgency of the EVAR procedure (Fig 3).
Patients treated with EVAR for ruptured AAA were signiﬁ-
cantly more likely to be lost to annual imaging follow-up
than were patients treated with EVAR for intact AAA (P <
.001). This effect was also seen when patients treated for
intact aneurysms were further stratiﬁed on the basis of ur-
gent/emergent status vs elective status. Patients undergoing
Fig 2. Kaplan-Meier (KM) analysis of all patients who underwent endovascular aneurysm repair (EVAR) between
2001 and 2008 demonstrating the proportion of patients not lost to imaging follow-up.
Fig 3. Kaplan-Meier (KM) analysis of all patients who underwent endovascular aneurysm repair (EVAR) between
2001 and 2008 demonstrating the proportion of patients not lost to imaging follow-up, stratiﬁed by presentation at the
time of repairdelective, urgent/emergent, ruptured.
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being lost to annual imaging follow-up than did patients
undergoing elective AAA repair (P < .001). This observed
increase in being lost to annual imaging follow-up occurredpredominantly during the ﬁrst 2 years of follow-up. The
subsequent rate of being lost to imaging follow-up during
years 3, 4, and 5 occurred at a similar rate across all groups
(Fig 3).
Table II. Independent determinants of being lost to
imaging follow-up after endovascular aneurysm repair
(EVAR)
Variable HR 95% CI
Age, years
65-69 Reference Reference
70-74 1.04 0.97-1.12
75-79 1.23 1.15-1.32
80-85 1.45 1.35-1.55
>85 2.03 1.88-2.20
U.S. region
East Reference Reference
Midwest 1.05 0.98-1.11
South 1.1 1.03-1.17
West 1.16 1.07-1.25
Comorbidities
Congestive heart failure 1.52 1.43-1.61
Cerebrovascular disease 1.07 1.01-1.15
Chronic obstructive
pulmonary disease
1.29 1.23-1.35
Chronic renal insufﬁciency 1.37 1.27-1.49
Diabetes 1.07 1.02-1.13
Cancer 1.12 1.06-1.19
Presentation
Elective nonruptured Reference Reference
Urgent/emergent
nonruptured
1.27 1.20-1.35
Ruptured 1.84 1.63-2.08
CI, Conﬁdence interval; HR, hazard ratio.
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loss to annual imaging follow-up that had the largest haz-
ard ratios were advanced age and aneurysm rupture on pre-
sentation (Table II). Additional independent predictors of
loss to annual imaging follow-up included previous his-
tories of congestive heart failure, chronic renal insufﬁ-
ciency, chronic obstructive pulmonary disease, cancer,
cerebrovascular disease, and diabetes and South and West
regions of the United States.
Prolonged imaging gap. Figure 4 demonstrates the
proportion of patients who received $1 imaging study
(CT, MRI, or duplex ultrasound) during each 2-year in-
terval after EVAR. Of the 18,914 patients alive 2 years after
EVAR, 94.8% received $1 imaging study after EVAR. For
the 13,307 patients alive 4 years after EVAR, 69.6%
received $1 imaging study between years 2 and 4 after
EVAR. For the 7666 patients alive 6 years after EVAR,
49.4% received $1 imaging study between years 4 and 6
after EVAR. For the 3239 patients alive 8 years after
EVAR, 36.6% received $1 imaging study between years 6
and 8 after EVAR.
DISCUSSION
This study demonstrates that in a large population of
Medicare beneﬁciaries who underwent EVAR between
2001 and 2008, 50% of patients were lost to annual imag-
ing follow-up by 5 years after EVAR. For the subset of pa-
tients with 8 years of follow-up data after EVAR,
substantive declines in imaging follow-up continued, withonly 37% undergoing an imaging study between years 6
and 8. These rates are surprisingly low, given the clear ev-
idence supporting the importance of annual imaging
follow-up for identifying correctable problems after
EVAR that can lead to aneurysm sac enlargement, rupture,
and death.5-10
It is possible that a proportion of the patients catego-
rized as “lost to annual imaging follow-up” were not truly
“lost” but may have stopped receiving follow-up by choice,
or they may have been told by their physician that they no
longer needed further follow-up. Either way, compliance
with recommended lifelong imaging follow-up after
EVAR was poor. The exact motivation leading to this
poor compliance is an interesting and important question
that, unfortunately, is beyond the scope of this study and
cannot be addressed with this data set.
Despite the critical importance of annual imaging
follow-up after EVAR, few studies have examined compli-
ance with this guideline-recommended management, and
U.S. data are limited to single-institution studies.5,6 Jones
et al analyzed follow-up compliance in 302 patients who
underwent EVAR at a single institution (1999-2005).11
During an average follow-up of 30 months, 33% of patients
had incomplete follow-up (deﬁned as missing $2 consecu-
tive imaging studies). In another single-center review with
a more heterogeneous population (patients underwent
EVAR, endovascular thoracic aneurysm repair, or medical
management for type B aortic dissection), imaging
follow-up compliance was assessed in 204 patients.12 At
an average follow-up of 28 months, 56% of patients were
lost to imaging follow-up (deﬁned as >1 year since last
imaging).
To our knowledge, our study provides the ﬁrst
population-based estimates of post-EVAR annual imaging
follow-up rates for the United States. In Europe, an attempt
has been made to better understand factors associated with
loss to imaging follow-up.16 The European Collaborating
Group on Stent-Graft Techniques for Abdominal Aortic
Aneurysm Repair recommends lifelong annual imaging
follow-up after EVAR. With use of data from 4433 patients
enrolled in this registry during the period 1996-2004, 65%
failed to comply with the recommended follow-up regimen.
On multivariable analysis, compliance was associated with
the number of comorbidities and cardiovascular risk factors
present. Patients who were hypertensive, actively smoked,
and deemed medically too high risk for open repair were
more likely to comply with imaging follow-up.
In contrast to the European ﬁndings, it appears that
Medicare beneﬁciaries are more likely to be lost to annual
imaging follow-up if they have multiple comorbidities pre-
viously diagnosed. Congestive heart failure, cerebrovascu-
lar disease, chronic obstructive pulmonary disease,
chronic renal insufﬁciency, diabetes, and cancer were asso-
ciated with a signiﬁcantly increased hazard of loss to annual
imaging follow-up. One possible explanation for this
ﬁnding may be that in patients with a number of active
long-term medical issues, the patient and treating physi-
cians may lose focus on surveillance of an AAA after
Fig 4. Prolonged imaging gap. Proportion of patients who received at least one imaging study (computed tomography
[CT], magnetic resonance imaging [MRI], or duplex ultrasound) during each 2-year interval that they were alive after
endovascular aneurysm repair (EVAR).
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burden of competing medical risks.
Older individuals were also more likely to be lost to
annual imaging follow-up. Not surprisingly, each 5-year
increment of advanced age was associated with a signiﬁcant
increase in being lost to imaging follow-up. Because the
duration of remaining life expectancy decreases with
advancing age, the perceived beneﬁt of regular surveillance
after EVAR may decrease as well. In a patient older than
85 years (hazards ratio for loss to imaging follow-up,
2.03), the value of performing a reintervention, even if a
problem is identiﬁed after EVAR, becomes less clear.
Surprisingly, patients who underwent EVAR in the
urgent/emergent setting and those who presented
with a ruptured AAA were signiﬁcantly more likely to
be lost to annual imaging follow-up. The reasons for
this are likely to be multifactorial. First, patients under-
going elective EVAR have been counseled by the treat-
ing physician, often on multiple visits, and may have a
better underlying understanding of their disease and
the critical importance of lifelong imaging follow-up.
Second, patients being treated in the urgent/emergent
setting are often treated outside of their established
health care network and are more likely to be lost to
follow-up. These ﬁndings point to an important oppor-
tunity for national quality improvement efforts to
enhance care coordination across providers of care and
to reward appropriate imaging follow-up among patients
at high risk for loss to follow-up. Novel ideas to improve
imaging follow-up compliance, such as physician-patient
contracts, improved preoperative education materials,
and ﬁnancial incentives directed at both patients and
physicians, need to be developed and tested.
There are several strengths and limitations inherent to
this study design. First, our cohort was limited to elderly
Medicare beneﬁciaries, and we cannot comment on post-
EVAR follow-up imaging rates among individuals youngerthan 65 years. Second, we restricted analyses to Medicare
fee-for-service enrollees, as Medicare managed care enroll-
ees frequently have incomplete claims and therefore incom-
plete capture of follow-up imaging data. If follow-up
imaging compliance is higher among Medicare Advantage
enrollees, our imaging compliance estimates may be low.
Offsetting this potential bias, we deﬁned loss to annual im-
aging follow-up liberally (2 years without an imaging
study) instead of using a more stringent deﬁnition (1 year
without an imaging study). This was deliberate to avoid
overestimating the rate of loss to annual imaging follow-
up. As a result, the true rate of loss to annual imaging
follow-up is likely to be signiﬁcantly higher than reported
here. Finally, it is possible that a proportion of the imaging
studies identiﬁed during the follow-up period were indi-
cated for reasons other than post-EVAR surveillance.
Whereas the AAA may have been imaged, we were unable
to know if a physician with expertise in evaluating an EVAR
repair reviewed the imaging study.
An important question that arises on the basis of these
data is, How many patients who were lost to imaging
follow-up progressed to AAA rupture after EVAR
compared with those who were not lost to imaging
follow-up? In many ways, this is the key clinical question
that begins to quantify the importance of annual lifelong
imaging follow-up after EVAR. Unfortunately, this is a
difﬁcult question to answer with administrative claims
data as the majority of patients who experience AAA
rupture do not make it to the hospital. As a result, these
events are not captured in administrative data such as the
Medicare ﬁles used in this study. Furthermore, we are un-
able to comment on the proportion of follow-up imaging
studies that demonstrated abnormalities related to the
EVAR procedure as the data set contains no results from
the imaging study. We are limited to being able to report
only whether or not they had an imaging study on the basis
of the claims submitted.
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These ﬁndings suggest that compliance with imaging
follow-up recommendations after EVAR in the United
States is well below the recommended rate. All patients,
and especially those of advanced age and those with multi-
ple comorbidities, should be counseled that their AAA,
despite having undergone endovascular treatment, still
carries a small but lifelong risk of rupture and therefore re-
quires lifelong annual imaging surveillance. Also, patients
undergoing EVAR urgently/emergently or for a ruptured
AAA appear to be at especially high risk for loss to annual
imaging follow-up and warrant increased attention to
improve long-term imaging follow-up rates. These ﬁndings
point to an important opportunity for quality improve-
ment, particularly in an era in which Medicare seeks to
expand its armament of quality improvement measures.
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Supplementary Table I (online only). International
Classiﬁcation of Diseases, Ninth Revision (ICD-9)
diagnosis codes and ICD-9 procedure codes used to
create the study cohort
Inclusion criteria
ICD-9 diagnosis code Deﬁnition
441.4 AAA without rupture
441.3 AAA with rupture
ICD-9 procedure code Deﬁnition
39.71 EVAR
Exclusion criteria
ICD-9 diagnosis code Deﬁnition
441.1, 441.2 TAAA with rupture
441.6, 441.7 TAAA without rupture
441.00-441.03 Aortic dissection
ICD-9 procedure code Deﬁnition
38.35, 38.45, 39.73 Thoracic aorta
38.46, 39.24, 39.26 Visceral artery or renal artery
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair;
TAAA, thoracoabdominal aortic aneurysm.
Supplementary Table II (online only). Billing codes
used to identify claims for an abdominal or pelvic imaging
study
Billing code Deﬁnition
CT scan abdomen/pelvis
74150 CT Abdomen w/o contrast
74160 CT Abdomen with contrast
74170 CT Abdomen with & w/o contrast
72192 CT Pelvis w/o contrast
72193 CT Pelvis with contrast
72194 CT Pelvis with & w/o contrast
74177 CT Abdomen & pelvis with contrast
74178 CT Abdomen & pelvis with & w/o contrast
74176 CT Abdomen & pelvis w/o contrast
74174 CT Angiogram abdomen & pelvis
74175 CT Angiogram abdomen
MRI scan abdomen/pelvis
74181 MRI Abdomen w/o contrast
74183 MRI Abdomen with & w/o contrast
72195 MRI Pelvis w/o contrast
72197 MRI Pelvis with & w/o contrast
74185 MRA Abdomen with & w/o contrast
72198 MRA Pelvis with & w/o contrast
Duplex scan abdomen/pelvis
93976/93975 Duplex scan of arterial inﬂow and venous
outﬂow of abdominal, pelvic, scrotal
contents and/or retroperitoneal organs
93979/93978 Duplex scan of aorta, inferior vena cava, iliac
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CT, Computed tomography; MRI, magnetic resonance imaging; w/o,
without.
